The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This report examines attitudes and views of parents as children head back to school amidst the rise in COVID-19 cases due to the delta variant. Nearly half of parents of children ages 12-17, who are currently eligible to receive a COVID-19 vaccine, say their child has already been vaccinated or will get the vaccine right away. The report examines parents' vaccine concerns and attitudes towards vaccine and mask mandates in schools.
A new Policy Watch, Early State Vaccination Data Raise Warning Flags for Racial Equity, explores the latest state-reported data on vaccination by race/ethnicity available on KFF’s COVID-19 state data and policy tracker. As of January 19, 2021, 17 states were reporting some vaccination data by race/ethnicity, including 16 states reporting the distribution of vaccinations by race/ethnicity. Black Americans’ share of vaccinations is smaller than their share of cases in 16 reporting states and smaller than…
On November 13, 2020, the Centers for Medicare and Medicaid Services (CMS) finalized revisions to the Medicaid managed care regulations which were proposed in November 2018. CMS previously finalized a major revision to these regulations in 2016. The November 2020 final rule is not a wholesale revision of the 2016 regulations but adopts changes in areas including network adequacy, beneficiary protections, quality oversight, and rates and payment.
This survey of Ryan White-funded providers examines the significant challenges posed by the COVID-19 pandemic on the people with HIV and the systems that serve them.
As of February 2021, there are three COVID-19 vaccines approved for emergency use in the U.S. and states are playing a central role in their timely distribution and prioritizing eligible populations. Because Medicaid covers for over 77 million enrollees, including groups disproportionately at risk of contracting COVID-19 as well as hard-to-reach groups, Medicaid agencies can be important partners for the public health agencies that are typically leading the state COVID-19 vaccination efforts. This brief provides…
The Peterson-KFF Health System Dashboard examines the U.S. health system's performance in four areas: access and affordability, health and well-being, health spending, and quality of care. Users can explore trends over time, as well as disparities and differences across demographic groups.
In this article for The Lancet, KFF’s Jennifer Kates and Lindsey Dawson, and five co-authors provide an overview of the coverage and financing landscape for HIV treatment and prevention in the U.S., discuss how the Affordable Care Act has changed the domestic health care system, examine the major programs that provide coverage and services, and identify remaining challenges. The article was published online on February 19, 2021. To access it at no charge, register for…
With supply having increased significantly and eligibility fully open to adults in all states as of April 19, this analysis estimates that COVID-19 vaccine supply will exceed demand across the U.S. over the next 2 to 4 weeks.
The October KFF Health Tracking Poll explores experiences with unpaid caregiving, and favorability of expansion of home and community based services (HCBS). It also examines experiences with difficulty affording and putting of health care services among seniors, favorability of the ACA and experience with determining eligibility for lower cost insurance as part of the COVID relief package.
This brief examines how leading federal and state policy options related to changes in Medicaid Drug Rebate Program (MDRP), drug pricing, and payment and management of the Medicaid prescription drug would affect state and federal governments as well as private industry (including drug manufacturers, managed care organizations, and pharmacies).
© 2026 KFF
